{
  "patent_number": "US 20250057964",
  "country": "US",
  "title": "Targeting Drugs with a Special Polysarcosine Polymer Chain",
  "original_title": "Ligand-drug-conjugate comprising a single molecular weight polysarcosine",
  "summary": "This patent describes a new way to deliver drugs, especially for cancer, by attaching them to a specific type of polymer called polysarcosine that has a very precise, single molecular weight.",
  "what_it_does": "This patent describes a Ligand-Drug-Conjugate (LDC) compound designed to deliver a drug, typically a cytotoxic drug, to a specific target in the body. The LDC (formula XV) uses a 'single molecular weight homopolymer' (Claim 1), which is preferably polysarcosine (Claim 2). This special polymer is connected to the drug via an 'orthogonal connector' (L), ensuring the polymer is positioned distinctly from the drug and its linker (X-D). The drug (D) can be released from the LDC using an optional 'cleavable moiety' (X), which might be triggered by conditions in the body, like acidic environments in lysosomes (Claim 9). For example, a cancer-targeting antibody (the ligand, Claim 5) could be attached to this polysarcosine chain, which then carries a chemotherapy drug directly to tumor cells, releasing it only when it reaches the target.",
  "what_it_does_not_cover": [
    "Does not cover Ligand-Drug-Conjugates that use homopolymers with a range of molecular weights, only those with a 'single molecular weight' (Claim 1).",
    "Does not cover LDCs where the polymer is not a 'homopolymer' (Claim 1), meaning it would not cover conjugates made with copolymers or other polymer types.",
    "Does not cover LDCs that use polymers other than polysarcosine as the single molecular weight homopolymer (Claim 2).",
    "Does not cover LDCs where the polymer is not in an 'orthogonal orientation' with respect to the drug and its linker (Claim 1).",
    "Does not cover drug conjugates where the drug is not attached via an 'orthogonal connector' (L) as defined (Claim 1)."
  ],
  "filed": "2024-09-24",
  "granted": null,
  "expires": "2044-09-24",
  "status": "active",
  "holder": "Mablink Bioscience SAS",
  "holder_url": "https://patentbrief.org/company/mablink-bioscience-sas",
  "inventors": [
    {
      "name": "Warren VIRICEL",
      "url": "https://patentbrief.org/inventor/warren-viricel"
    }
  ],
  "times_cited": 0,
  "tags": [
    "pharmaceutical",
    "biotech",
    "materials"
  ],
  "abstract": "The invention relates to a Ligand-Drug-Conjugate (LDC) comprising a single molecular weight homopolymer, in particular a single molecular weight polysarcosine.",
  "url": "https://patentbrief.org/patent/us/20250057964/ligand-drug-conjugate-comprising-a-single-molecular-weight-polysarcosine",
  "markdown_url": "https://patentbrief.org/patent/us/20250057964/ligand-drug-conjugate-comprising-a-single-molecular-weight-polysarcosine/md",
  "google_patents_url": "https://patents.google.com/patent/US20250057964",
  "relatedPatents": [
    {
      "patentNumber": "9884123",
      "countryCode": "US",
      "title": "Targeted Platinum Drugs for Cancer Treatment",
      "url": "https://patentbrief.org/patent/us/9884123/ligand-targeted-molecules-and-methods-thereof"
    },
    {
      "patentNumber": "20210301031",
      "countryCode": "US",
      "title": "Targeted Cancer Drugs Using Antibodies and Polymer Scaffolds",
      "url": "https://patentbrief.org/patent/us/20210301031/napi2b-targeted-antibody-drug-conjugates-and-methods-of-use-thereof"
    },
    {
      "patentNumber": "12121527",
      "countryCode": "US",
      "title": "Making Cancer-Fighting Antibody Drugs Safer with Precise Attachment",
      "url": "https://patentbrief.org/patent/us/12121527/anthracycline-based-antibody-drug-conjugates-having-high-in-vivo-tolerability"
    },
    {
      "patentNumber": "10772965",
      "countryCode": "US",
      "title": "A Chemical Linker for Attaching Drugs to Antibodies",
      "url": "https://patentbrief.org/patent/us/10772965/covalent-linkers-in-antibody-drug-conjugates-and-methods-of-making-and-using-the"
    },
    {
      "patentNumber": "10391181",
      "countryCode": "US",
      "title": "A Stable Recipe for a Cancer-Fighting Antibody Drug",
      "url": "https://patentbrief.org/patent/us/10391181/cyclodextrin-and-antibody-drug-conjugate-formulations"
    }
  ]
}